A Study to Evaluate the Drug Levels, Metabolism, and Removal of BMS-986322 in Healthy Adult Male Participants

Healthy Male Participants Clinical Trial

Official title:
A Phase 1, Single-center, Open-label Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of [14C] BMS-986322 in Healthy Adult Male Participants

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the drug levels, metabolism, and removal of BMS-986322 in healthy adult male participants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Male Participants

Clinical Trial Details

NCT number	NCT06088264
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	Phase 1
Start date	October 31, 2023
Completion date	December 22, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01707342` - A Study to Assess the Absolute Bioavailability and Pharmacokinetics of Simeprevir (TMC435) Administered as Single Oral Doses of TMC435 and an Intravenous Microdose of [3H]-TMC435 in Healthy Male Patients	Phase 1
Completed	`NCT03960502` - A Safety and Pharmacokinetic Study of AG-881 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881	Phase 1
Active, not recruiting	`NCT06189508` - A Study to Evaluate Single Subcutaneous Doses of NXT007 Among Injection Sites Abdomen, Upper Arm, and Thigh in Healthy Male Participants	Phase 1
Completed	`NCT03922633` - A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants	Phase 1
Completed	`NCT03444818` - A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants	Phase 1